Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $220.57 USD
Change Today +3.21 / 1.48%
Volume 2.1M
MCK On Other Exchanges
Symbol
Exchange
New York
Mexico
Frankfurt
As of 8:04 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

mckesson corp (MCK) Snapshot

Open
$218.10
Previous Close
$217.36
Day High
$220.73
Day Low
$216.97
52 Week High
05/19/15 - $243.61
52 Week Low
10/15/14 - $178.28
Market Cap
51.3B
Average Volume 10 Days
1.5M
EPS TTM
$9.30
Shares Outstanding
232.4M
EX-Date
08/28/15
P/E TM
23.7x
Dividend
$1.12
Dividend Yield
0.44%
Current Stock Chart for MCKESSON CORP (MCK)

mckesson corp (MCK) Details

McKesson Corporation delivers pharmaceuticals, medical supplies, and health care information technologies to the healthcare industry in the United States and internationally. The company operates in two segments, McKesson Distribution Solutions and McKesson Technology Solutions. The McKesson Distribution Solutions segment distributes ethical and proprietary drugs and equipment, and health and beauty care products. This segment also provides specialty pharmaceutical solutions for biotech and pharmaceutical manufacturers; and practice management, technology, clinical support, and business solutions to oncology and other specialty practices operating in the community setting. In addition, this segment offers medical-surgical supply distribution, equipment, logistics, and other services to healthcare providers through a network of distribution centers in the United States; sells financial, operational, and clinical solutions for pharmacies; and provides consulting, outsourcing, and other services. The McKesson Technology Solutions segment delivers enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions; and connectivity, outsourcing, and other services, such as remote hosting and managed services to healthcare organizations. This segment’s product portfolio is designed to address various healthcare clinical and business performance needs ranging from medication safety and information access to revenue cycle management, resource utilization, and physician adoption of electronic health records. It serves integrated delivery networks, hospitals, physician practices, home healthcare providers, retail pharmacies, and payers. McKesson Corporation was founded in 1833 and is headquartered in San Francisco, California.

70,400 Employees
Last Reported Date: 05/12/15
Founded in 1833

mckesson corp (MCK) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $1.7M
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $800.0K
Executive Vice President and Group President
Total Annual Compensation: $1.1M
Executive Vice President and Group President
Total Annual Compensation: $684.0K
President of North American Pharmaceutical Di...
Total Annual Compensation: $684.0K
Compensation as of Fiscal Year 2015.

mckesson corp (MCK) Key Developments

McKesson Corporation Approves Amendments to the Company's Amended and Restated By-Laws

McKesson Corporation announced at the annual meeting held on July 29, 2015, stockholders approved amendments to the company's Amended and Restated By-Laws to allow eligible stockholders to place their own director nominees on the company's proxy card, along with the candidates nominated by the Board (the Proxy Access By-Law Amendments). The Proxy Access By-Law Amendments specify a 3%/three-year holding requirement for eligibility and state that an eligible stockholder or group of stockholders who complies with the specified procedural and disclosure requirements may include stockholder-nominated director candidates in the company's proxy materials to fill up to 20% of the available board seats.

McKesson Corporation Declares Quarterly Dividend, Payable on October 1, 2015

The Board of Directors of McKesson Corporation declared a regular dividend of twenty-eight cents per share on common stock, a four cent increase from the prior quarter. The dividend will be payable on October 1, 2015, to stockholders of record on September 1, 2015.

McKesson Corporation Reports Unaudited Consolidated Earnings Results for the First Quarter Ended June 30, 2015; Provides Earnings Guidance for the Fiscal Year Ending March 31, 2016

McKesson Corporation reported unaudited consolidated earnings results for the first quarter ended June 30, 2015. For the quarter, the company reported revenues of $47,546 million against $43,476 million a year ago. Operating income was $931 million against $681 million a year ago. Income from continuing operations before income taxes was $855 million against $604 million a year ago. Income from continuing operations after tax was $599 million or $2.50 per diluted share against $419 million or $1.76 per diluted share a year ago. Net income attributable to the company was $576 million or $2.45 per diluted share against $403 million or $1.72 per diluted share a year ago. Net cash provided by operating activities was $454 million against $182 million a year ago. Property acquisitions were $77 million against $83 million a year ago. Capitalized software expenditures were $43 million against $33 million a year ago. First-quarter Adjusted Earnings per diluted share was $3.14, up 27% compared to $2.47 a year ago. On a constant currency basis, Adjusted Earnings per diluted share increased 30% over the prior year. The company expects adjusted earnings per diluted share between $12.36 and $12.86 for the fiscal year ending March 31, 2016, based on an exchange rate of $1.10 per Euro.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MCK:US $220.57 USD +3.21

MCK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Aetna Inc $112.97 USD -1.18
AmerisourceBergen Corp $105.75 USD +1.28
Cardinal Health Inc $84.98 USD +1.64
Express Scripts Holding Co $90.07 USD -0.18
UnitedHealth Group Inc $121.40 USD +0.84
View Industry Companies
 

Industry Analysis

MCK

Industry Average

Valuation MCK Industry Range
Price/Earnings 26.6x
Price/Sales 0.3x
Price/Book 5.8x
Price/Cash Flow 31.1x
TEV/Sales 0.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MCKESSON CORP, please visit www.mckesson.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.